Abstract
BackgroundPrior studies suggest monocyte chemoattractant protein-1 (MCP-1) may be useful for risk stratifying ED patients with chest pain. We hypothesise that MCP-1 will be predictive of 90-day major adverse cardiovascular...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have